
Congenital Myasthenic Syndrome 19: Glycosylation Genes
Glycosylation genes feature strongly in CMS19, and variant frequency differs by population. Testing confirms a diagnosis that is easily missed and guides management.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Glycosylation genes feature strongly in CMS19, and variant frequency differs by population. Testing confirms a diagnosis that is easily missed and guides management.

A newborn with unexplained diarrhea may carry a SPINT2 mutation; CSSD8 blocks intestinal sodium absorption, and testing supports early diagnosis and electrolyte care.

Inherited in an X-linked recessive pattern, CSNB1H mainly affects males and does not progress; carrier testing, myopia and strabismus findings shape family planning.

Benign and malignant tumors, skin lesions and developmental differences mark CS7; because PTEN changes pass on dominantly, relatives can be tested and monitored.

Researchers have tied 57 genes to craniosynostosis, and next-generation sequencing is described as the route to pinpointing the change behind this subtype.

Explore how genetic testing aids in diagnosing Cutis Laxa, Autosomal Dominant 3, involving the ALDH18A1 gene, leading to early intervention and personalized care.

Inherited changes in DDX41 disrupt blood cell production in the bone marrow and raise the risk of myelodysplastic syndromes and acute myeloid leukemia.

PIEZO1 mutations disturb ion transport across the red cell membrane, dehydrating cells and causing hemolytic anemia with fatigue, jaundice and splenomegaly.